提醒成功
搜索
| 产品规范 | |
|---|---|
| Type | In Vivo - Reseach Grade Antibody |
| Host | CHO cells |
| catalog# | B00004 |
| Application | Flow cytometry, animal model study |
| Aliases | Anti-RANKL Human Monoclonal Antibody |
| Size/Concentration | 1mg/5mg/20mg |
| Isotype | Human IgG2 |
| Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Human RANK Ligand |
| Formulation | PBS, pH 7.4 |
Description |
|---|
Denosumab, a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone. |
Denosumab Biosimilar, Human RANKL Monoclonal Antibody B00004
规格:
- 1mg
- 5mg
- 20mg
数量:
-
+
说明书:
¥1625
-
咨询
-
收藏

微信/QQ登录


首页